Cargando…
Uncovering NOTCH1 as a Promising Target in the Treatment of MLL-Rearranged Leukemia
MLL rearrangement (MLLr) is responsible for the development of acute leukemias with poor outcomes. Therefore, new therapeutic approaches are urgently needed. The NOTCH1 pathway plays a critical role in the pathogenesis of many cancers including acute leukemia. Using a CRISPR/Cas9 MLL-AF4/-AF9 transl...
Autores principales: | Fischer, Jacqueline, Erkner, Estelle, Fitzel, Rahel, Radszuweit, Pia, Keppeler, Hildegard, Korkmaz, Fulya, Roti, Giovanni, Lengerke, Claudia, Schneidawind, Dominik, Schneidawind, Corina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572120/ https://www.ncbi.nlm.nih.gov/pubmed/37833915 http://dx.doi.org/10.3390/ijms241914466 |
Ejemplares similares
-
Targeting MYC in combination with epigenetic regulators induces synergistic anti-leukemic effects in MLLr leukemia and simultaneously improves immunity
por: Fitzel, Rahel, et al.
Publicado: (2023) -
Only Hematopoietic Stem and Progenitor Cells from Cord Blood Are Susceptible to Malignant Transformation by MLL-AF4 Translocations
por: Secker, Kathy-Ann, et al.
Publicado: (2020) -
PB1803: SMAD1 IS A TUMOR SUPPRESSOR IN ACUTE MYELOID LEUKEMIA WITH MLL REARRANGEMENT
por: Dietsche, Lisa, et al.
Publicado: (2023) -
Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia
por: Schmid, Hannes, et al.
Publicado: (2018) -
MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis
por: Secker, Kathy-Ann, et al.
Publicado: (2020)